Netwerk
J. J. Swen
- Dutch Working Group Focusing on Genotype-related Sunitinib-induced Toxicity (SUTOX Consortium)
- Leiden University
- Department of Clinical Pharmacy and Toxicology
- Dutch SUTOX consortium
Externe Persoon: Externe persoon
H. J. Guchelaar
- Dutch Working Group Focusing on Genotype-related Sunitinib-induced Toxicity (SUTOX Consortium)
- Leiden University
- University of Groningen
- Department of Clinical Pharmacy and Toxicology
- Dutch SUTOX consortium
Externe Persoon: Externe persoon
Hans Gelderblom
- Leiden University
- Dutch Working Group Focusing on Genotype-related Sunitinib-induced Toxicity (SUTOX Consortium)
- Leiden UMC
- Dutch SUTOX consortium
Externe Persoon: Externe persoon
D. Castellano
- Hospital Universitario 12 de Octubre
- Spanish Oncology Genitourinary Group
Externe Persoon: Externe persoon
Cristina Rodríguez-Antona
- Instituto de Salud Carlos III
- Centro Nacional de Investiga-ciones Oncológicas
Externe Persoon: Externe persoon
J. García-Donas
- Spanish Oncology Genitourinary Group
- Clara Campal Comprehensive Cancer Center
- HM Hospitales—Centro Integral Oncológico HM Clara Campal
Externe Persoon: Externe persoon
Ron H.J. Mathijssen
- Erasmus University Rotterdam
- Dutch Working Group Focusing on Genotype-related Sunitinib-induced Toxicity (SUTOX Consortium)
- Dutch SUTOX consortium
- Center for Personalised Cancer Treatment
Externe Persoon: Externe persoon
E. Boven
- Dutch Working Group Focusing on Genotype-related Sunitinib-induced Toxicity (SUTOX Consortium)
- VU University Medical Center
- Vrije Universiteit Amsterdam
- Dutch SUTOX consortium
Externe Persoon: Externe persoon
Max Roessler
- CESAR Central European Society for Anticancer Drug Research-EWIV
- CESAR Central Office (CCO)
Externe Persoon: Externe persoon
Lambertus A.L.M. Kiemeney
- Radboud University Nijmegen
- Netherlands Association of Comprehensive Cancer Centres
- Netherlands Cancer Institute
- Comprehensive Cancer Centers
- Erasmus University Rotterdam
- Comprehensive Cancer Center the Netherlands
- Comprehensive Cancer Centers-Amsterdam South Netherlands East Netherlands Middle Netherlands Norther
- deCODE Genetics
Externe Persoon: Externe persoon
Xiaoyan Liu
- Leiden University
- Shandong University
- Dutch SUTOX consortium
Externe Persoon: Externe persoon
Lidwien M Hanff
Externe Persoon: Externe persoon
Bastiaan Nuijen
- Netherlands Cancer Institute
- Slotervaart Hospital
- Antoni van Leeuwenhoek Hospital
Externe Persoon: Externe persoon
Lidwien M. Hanff
- Princess Máxima Center for Pediatric Oncology
- Erasmus University Rotterdam
Externe Persoon: Externe persoon
Anne Cambon-Thomsen
- Université Fédérale Toulouse Midi-Pyrénées
- Université de Toulouse, UPS
- Institut national de la santé et de la recherche médicale
Externe Persoon: Externe persoon
Stefan Sleijfer
- Erasmus University Rotterdam
- Center for Personalised Cancer Treatment
- Center for Personalized Cancer Treatment
Externe Persoon: Externe persoon
Christina Hulsbergen-Van De Kaa
- Radboud University Nijmegen
- Laboratory of Pathology East Netherlands (LABPON)
Externe Persoon: Externe persoon
Eleonora Heeremans
Externe Persoon: Externe persoon
Lodewyk F.A. Wessels
- Cancer Genomics Center (CGC)
- Netherlands Cancer Institute
- Oncode Institute
- Delft University of Technology
- Antoni van Leeuwenhoek Hospital
Externe Persoon: Externe persoon
Annemarie M.L. Peek
- VU University Medical Center
- University of Groningen
- Princess Máxima Center for Pediatric Oncology
Externe Persoon: Externe persoon
Huixin Yu
- Netherlands Cancer Institute
- Antoni van Leeuwenhoek Hospital
- Slotervaart Hospital
Externe Persoon: Externe persoon
M. Kinzig
- IBMP - Institute for Biomedical and Pharmaceutical Research
Externe Persoon: Externe persoon
Lianne M. Haveman
- University of Amsterdam
- Princess Máxima Center for Pediatric Oncology
Externe Persoon: Externe persoon
Valery Hogenes
Externe Persoon: Externe persoon
Mary M. Lee
Externe Persoon: Externe persoon
Jetske Graafsma
Externe Persoon: Externe persoon
F. Sörgel
- IBMP - Institute for Biomedical and Pharmaceutical Research
Externe Persoon: Externe persoon
C. Stelzer
- IBMP - Institute for Biomedical and Pharmaceutical Research
Externe Persoon: Externe persoon
Ron H.N. Van Schaik
- Erasmus University Rotterdam
- Department of Clinical Chemistry
Externe Persoon: Externe persoon
Henk-Jan Guchelaar
Externe Persoon: Externe persoon
Anne Y. Warren
- Cambridge University Hospitals NHS Foundation Trust
- University of Cambridge
Externe Persoon: Externe persoon
Maud van der Kleij
Externe Persoon: Externe persoon
Martijn P. Lolkema
- Utrecht University
- Erasmus University Rotterdam
- Center for Personalized Cancer Treatment
- Center for Personalised Cancer Treatment
Externe Persoon: Externe persoon
Kari Stefansson
- deCODE Genetics
- University of Iceland
- Landspitali University Hospital
Externe Persoon: Externe persoon
B. Moritz
- CESAR Central Office (CCO)
- CESAR Central European Society for Anticancer Drug Research-EWIV
Externe Persoon: Externe persoon
G van den Berg
Externe Persoon: Externe persoon
Nynke Schuiling-Veninga
Externe Persoon: Externe persoon
Neeltje Steeghs
- Netherlands Cancer Institute
- Utrecht University
- Antoni van Leeuwenhoek Hospital
- The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
- Center for Personalised Cancer Treatment
Externe Persoon: Externe persoon